methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet
- RxCUI
- 1995461
- RxNorm name
- methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet
- Display name
- methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet
- Full name
- methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Trigen Laboratories, LLC | c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 1995461 |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 18024571-4505-6d51-e063-6294a90a1972 | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 1995461 |
| Methylphenidate Hydrochloride | METHYLPHENIDATE HYDROCHLORIDE | Northstar Rx LLC | 768bf181-d0d8-49e5-9c87-cacbb069e0b2 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 1995461 |
| RELEXXII | METHYLPHENIDATE HYDROCHLORIDE | Vertical Pharmaceuticals, LLC | 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | 1995461 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f | methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet | PSN | 54 | These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | 20260424 |
| c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f | 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet | SCD | 54 | These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | 20260424 |
| c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f | methylphenidate hydrochloride 72 MG 24 HR Extended Release Oral Tablet | SY | 54 | These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | 20260424 |
| 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet | PSN | 18 | These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 2000 | 20250926 |
| 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet | SCD | 18 | These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 2000 | 20250926 |
| 22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d | methylphenidate hydrochloride 72 MG 24 HR Extended Release Oral Tablet | SY | 18 | These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 2000 | 20250926 |
| 18024571-4505-6d51-e063-6294a90a1972 | methylphenidate hydrochloride 72 MG 24 HR Extended Release Oral Tablet | SY | 2 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260424 |
| 18024571-4505-6d51-e063-6294a90a1972 | methylphenidate HCl 72 MG 24HR Extended Release Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260424 |
| 18024571-4505-6d51-e063-6294a90a1972 | 24 HR methylphenidate hydrochloride 72 MG Extended Release Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260424 |